Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Qiyao Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-7110-0995; OpenAlex author ID A5078001102. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 3 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 6

  1. Integrated spatial omics of metabolic reprogramming and the tumor microenvironment in pancreatic cancer. First author DOI 10.1016/j.isci.2025.112681↗
  2. Metabolic and immune crosstalk between cancer-associated fibroblasts and pancreatic cancer cells. Co-author DOI 10.1186/s12967-025-07164-0↗
  3. Emerging mechanisms and promising approaches in pancreatic cancer metabolism. Co-author DOI 10.1038/s41419-024-06930-0↗
  4. Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma. First author DOI 10.1038/s41598-021-96470-w↗
  5. Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer. Co-author DOI 10.1042/bsr20210337↗
  6. Immune Subtypes Based on Immune-Related lncRNA: Differential Prognostic Mechanism of Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.698296↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ziwen Liu · 3 shared papers, 2024–2025 · strength 0.77
  2. Hao Wu · 2 shared papers, 2024–2025 · strength 0.53
  3. Mengwei Wu · 2 shared papers, 2024–2025 · strength 0.50
  4. Wenzhi Guo · 3 shared papers, 2021 · strength 0.47
  5. Qingyuan Zheng · 3 shared papers, 2021 · strength 0.47
  6. Xiao Yu · 2 shared papers, 2021 · strength 0.32
  7. Bingrong Chen · 1 shared paper, 2025 · strength 0.27
  8. Lin Chen · 1 shared paper, 2025 · strength 0.27
  9. Hao Wu · 1 shared paper, 2025 · strength 0.25
  10. Xiao Yu · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.